Your browser doesn't support javascript.
loading
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia A M; Nishida, Naoshi; Schönlein, Martin; von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J; Sharma, Rohini.
Afiliación
  • Vithayathil M; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • D'Alessio A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Fulgenzi CAM; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Nishida N; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Schönlein M; Division of Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • von Felden J; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Schulze K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wege H; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Saeed A; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wietharn B; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hildebrand H; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, Kansas, USA.
  • Wu L; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, Kansas, USA.
  • Ang C; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, Kansas, USA.
  • Marron TU; Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, Mount Sinai Hospital, New York, New York, USA.
  • Weinmann A; Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, Mount Sinai Hospital, New York, New York, USA.
  • Galle PR; Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, Mount Sinai Hospital, New York, New York, USA.
  • Bettinger D; I. Medical Department, University Medical Center Mainz, Mainz, Germany.
  • Bengsch B; I. Medical Department, University Medical Center Mainz, Mainz, Germany.
  • Vogel A; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Faculty of Medicine, Freiburg University Medical Center, University of Freiburg, Freiburg, Germany.
  • Balcar L; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Faculty of Medicine, Freiburg University Medical Center, University of Freiburg, Freiburg, Germany.
  • Scheiner B; University of Freiburg, Signalling Research Centers BIOSS and CIBSS, Freiburg, Germany.
  • Lee PC; German Cancer Consortium (DKTK), Partner Site, Freiburg, Germany.
  • Huang YH; Hannover Medical School, Hannover, Germany.
  • Amara S; Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Muzaffar M; Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Naqash AR; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Cammarota A; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Personeni N; Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Pressiani T; Division of Hematology/Oncology, East Carolina University, Greenville, North Carolina, USA.
  • Pinter M; Division of Hematology/Oncology, East Carolina University, Greenville, North Carolina, USA.
  • Cortellini A; Division of Hematology/Oncology, East Carolina University, Greenville, North Carolina, USA.
  • Kudo M; Medical Oncology/TSET Phase 1 Program, Stephenson Cancer Center, University of Oklahoma, Norman, Oklahoma, USA.
  • Rimassa L; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Pinato DJ; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Italy.
  • Sharma R; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Liver Int ; 42(11): 2538-2547, 2022 11.
Article en En | MEDLINE | ID: mdl-35986902
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Aged / Humans Idioma: En Revista: Liver Int Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Aged / Humans Idioma: En Revista: Liver Int Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido